Abeona Therapeutics Inc.

11/12/2024 | Press release | Distributed by Public on 11/12/2024 06:36

Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa